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Objective: The aim of this study was to estimate lifetime risk of knee and hip replacement following a GP
diagnosis of osteoarthritis and assess how this risk varies with patient characteristics.
Methods: Routinely collected data from Catalonia, Spain, covering 2006 to 2015, were used. Study par-
ticipants had a newly recorded GP diagnosis of knee or hip osteoarthritis. Parametric survival models
were specified for risk of knee/hip replacement and death following diagnosis. Survival models were
combined using a Markov model and lifetime risk estimated for the average patient profile. The effects of
age at diagnosis, sex, comorbidities, socioeconomic status, body mass index (BMI), and smoking on risk
were assessed.
Results: 48,311 individuals diagnosed with knee osteoarthritis were included, of whom 2,561 underwent
knee replacement. 15,105 individuals diagnosed with hip osteoarthritis were included, of whom 1,247
underwent hip replacement. The average participant's lifetime risk for knee replacement was 30% (95%
CI: 25e36%) and for hip replacement was 14% (10e19%). Notable patient characteristics influencing
lifetime risk were age at diagnosis for knee and hip replacement, sex for hip replacement, and BMI for
knee replacement. BMI increasing from 25 to 35 was associated with lifetime risk of knee replacement
increasing from 24% (20e28%) to 32% (26e37%) for otherwise average patients.
Conclusion: Knee and hip replacement are not inevitable after an osteoarthritis diagnosis, with average
lifetime risks of less than a third and a sixth, respectively. Patient characteristics, most notably BMI,
influence lifetime risks.
© 2019 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Osteoarthritis is a clinical syndrome of failure of the joint
characterised by joint pain, functional limitation, and reduced
quality of life1. The hip and knee are the principal large joints
affected by osteoarthritis. Following diagnosis of knee or hip oste-
oarthritis, patient care is primarily managed in primary care. A
broad range of non-pharmacological and pharmacologicalR. Pinedo-Villanueva, Botnar
.
. Pinedo-Villanueva).
r Ltd on behalf of Osteoarthritis Re
d/4.0/).interventions are available as initial treatments after diagnosis2.
However, if patients develop persistent pain and functional
impairment, they may be offered a knee or hip replacement.3,4
One of the barriers to implementing recommended osteoar-
thritis management after diagnosis is inaccurate beliefs about the
disease process and progression among health professionals and
patients5. There is general negativity around the condition, with a
prevailing belief that the development of osteoarthritis is an un-
avoidable consequence of aging and that further deterioration is
inevitable6. This pessimism may lead to apathy or avoidance when
managing people with osteoarthritis7, which may explain the
limited adherence to treatment guidelines.8search Society International. This is an open access article under the CC BY-NC-ND
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structural deterioration is not a predictable consequence of aging1.
Further progression of osteoarthritis also does not appear to be
inevitable. In two community-based studies, for example, 39% of
knees with radiographic knee osteoarthritis had not worsened after
15 years9 while 35% of hips with radiographic hip osteoarthritis had
not progressed after 8 years10. Individuals with osteoarthritis
experience different symptom trajectories. In one study, disability
progressively worsened over time for only 24% of patients. The
remaining patients were stable, had short-term fluctuations, or
steadily improved over time.11
Better understanding of prognosis has been identified as a
particular area of unmet need in patients with osteoarthritis12, and
patients desire clear and understandable information13. The life-
time risks of knee and hip replacement would satisfy these re-
quirements and give patients and healthcare providers a better idea
of an individual's future healthcare needs. Understanding the effect
of modifiable and non-modifiable patient characteristics on life-
time risk can help instigate self-management and patient-driven
treatments following diagnosis.
In this study, we estimated the lifetime risks of knee and hip
replacement following a GP diagnosis of knee and hip osteoar-
thritis, respectively. We then assessed the effect of patient char-
acteristics on lifetime risk.
Methods
Setting
This analysis was based on actual practice data from patients
from Catalonia, Spain. Individual-level primary care data were
extracted from the Sistema d’Informacio pel Desenvolupament de la
Investigacio a l’Atencio Primaria (SIDIAP). SIDIAP (www.sidiap.org)
is a database containing patient records of 80% of the Catalan
population and is highly representative of the population in terms
of geographical, age, and sex distributions14. It has been used
extensively for research15. About 30% of the contributing practices
are also linked to the regional Conjunt Mínim Basic de Dades
(CMBD), a database containing details of admissions to every hos-
pital of Catalonia. The linked records gave us a total source popu-
lation of 1.7 million active subjects for the period 1 January 2006 to
31 December 2015.
Study participants
Individuals were eligible for inclusion into the study if they had
an incident diagnosis of knee or hip osteoarthritis. Diagnostic
coding in SIDIAP is based on ICD-10 codes. The recording of knee
and hip osteoarthritis have previously been validated, with a
sensitivity of 94% and specificity of 71% when compared to self-
reported physician diagnosed osteoarthritis16. A further validation
using free text records review confirmed the quality of osteoar-
thritis diagnosis in SIDIAP17. Individuals were excluded if they were
younger than 50 at their date of diagnosis, had less than 1year of
observation time prior to their diagnosis, had a prior diagnosis of
inflammatory arthritis, or had a knee or hip replacement recorded
before or on their date of diagnosis. The identification of knee and
hip replacement is summarised in the outcomes section below.
Participant characteristics at diagnosis
Participant characteristics at diagnosis were extracted from the
primary care records. Age and sex were extracted. Participants’
comorbidities were summarised using the Charlson score, with
possible scores of 0, 1, 2, or 3þ, and a higher score indicating ahigher degree of comorbidity18. All observation time prior to the
index diagnosis of osteoarthritis were used to identify generate this
score. Socioeconomic status was summarised using MEDEA, a
census-based indicator that has a distinct category for those living
in rural areas19. MEDEA has previously been used to assess the
effect of socioeconomic status on the risk of hand, hip, and knee
osteoarthritis in Catalonia20. Participants were grouped by MEDEA
quintile (first indicating least deprived and fifth most deprived), or
as living in a rural area.
We extracted the most recent record of body mass index (BMI)
and smoking status (non-smoker, ex-smoker, or current smoker)
before the osteoarthritis diagnosis and kept only those recorded
within a year of diagnosis. For the purposes of summarising the
observed outcomes, continuous variables were categorised. BMI
was categorised following the World Health Organisation cate-
gories: normal or underweight (BMI <25), overweight (25
and < 30), obese class I (30 and < 35), obese class II (35
and< 40), and obese class III (40). Agewas categorised by splitting
the data into quartiles (with first indicating the youngest and fourth
the oldest).
Outcomes
Instances of total knee and hip replacement (ICD-9 procedure
codes 8154 and 8151) were identified using linked hospital records,
with the database used collecting details of admissions to every
public and private hospital of Catalonia21. All knee and hip re-
placements were included in the analysis, and so procedures were
not necessarily attributable to the prior osteoarthritis diagnosis.
Deaths were identified based on recorded date of death in SIDIAP.
In the absence of a knee or hip replacement or death during the
study period, subjects were censored at the date of exit from a GP
practice linked to SIDIAP (e.g., due to moving out of Catalonia or
changing practice within Catalonia to one not linked to SIDIAP) or
the end of the study (31 December 2015).
Statistical methods
Comparison of cumulative incidence of knee/hip replacement
Observed knee and hip replacement over 9 years following
diagnosis of knee or hip osteoarthritis were summarised by their
cumulative incidence. Cumulative incidence allows the incidence of
an event to be estimated while taking competing risk into ac-
count22. We summarised cumulative incidence for the study pop-
ulations as a whole and compared cumulative incidence stratified
by participant characteristics of interest (age, sex, Charlson score,
MEDEA quintile or living rurally, BMI, and smoking status).
Estimating parametric survival models for risks of knee/hip
replacement and mortality
Parametric survival models were estimated for cause-specific
risks of knee/ hip replacement and death following diagnosis of
knee or hip osteoarthritis, respectively. Such models require an
assumption of the underlying distribution of the events of interest.
Alternative distributions were compared and chosen on the basis of
their fit to the observed data and the plausibility of extrapolation23.
Further details on the choice of distributions is provided in Ap-
pendix Section 3, with the chosen distributions shown in Appendix
Fig. A2-A4.
Univariable and multivariable survival models were estimated
for each of the participant characteristics of interest. Non-linearity
in continuous variables was incorporated through the use of
polynomials, if their inclusion improved fit relative to specifying a
linear relationship. Fit was assessed by comparing Akaike infor-
mation criteria (AIC). Non-proportionality in hazards was assessed
E. Burn et al. / Osteoarthritis and Cartilage 27 (2019) 1627e1635 1629using a visual inspection of a log-log plot and by testing the
weighted residuals24. As there was evidence of non-proportionality
in age for risks of knee and hip replacement, the models were
estimated separately for each of the age groups, with age included
as an explanatory variable within each of the stratified models.25
Missing data in MEDEA, BMI, and smoking status was addressed
using multiple imputation, with 50 imputed datasets generated.
Both explanatory variables and outcomes were used as predictors
for missing data, with predictive mean matching used for BMI and
multinomial logit models used for MEDEA and smoking status.
Hazard ratios and corresponding 95% confidence intervals (CIs)
were calculated using Rubin's rules. Estimates from models based
on complete case data were also provided for comparison.
Estimating lifetime risk
To estimate lifetime risk, parametric survival models for knee
replacement and death or hip replacement and death were com-
bined using a state-based cohort Markov model. For lifetime risk of
knee replacement, a cohort of individuals began as being diagnosed
with knee osteoarthritis and then they remained in the diagnosis
state or progressed to either the knee replacement or death state as
time progressed in yearly cycles. An equivalent structure was used
for lifetime risk of hip replacement following a diagnosis of hip
osteoarthritis.
Transition probabilities for knee and hip replacement were
based exclusively on the parametric survival models estimated for
these events. These models were extrapolated beyond the 9 years
of observed data to participants’ total remaining lifetime. Transition
probabilities for death were based on the relevant parametric
models for the first 9 years of the model, after which they were
assumed to revert to estimates based on age- and sex-specific
lifetables for Spain26. Estimated hazard ratios were similar across
multiply imputed datasets and so to reduce computational time,
lifetime risks were estimated using the survival models estimated
on the first imputed dataset. Parameter uncertainty was incorpo-
rated using 1,000 bootstrapped models.
The models were first run for cohorts of individuals with
average characteristics (median for continuous variables and mode
for categorical ones) for those diagnosed with knee replacement
and hip replacement, separately. The partial effect of explanatory
factors on lifetime risk was assessed by re-running the models with
participant profiles varying in the explanatory factor of interest,
while holding other characteristics constant at their average. For
the partial effect of continuous variables, a smoothed linewas fitted




48,311 and 15,105 individuals were included in the knee and hip
osteoarthritis cohorts, respectively. A study inclusion flow chart is
provided in Appendix Fig. A1. The characteristics of these in-
dividuals are summarised in Table I. The median prior observation
time over which prior diagnoses and events could be observed was
5 years (with an interquartile range of 3e8 years). A comparison of
those with and without missing data in socioeconomic status
(MEDEA), BMI, or smoking status is given in Appendix Table A1, and
combinations of missing data are summarised in Appendix Figs. A2
and A3. Individuals with missing data were generally younger and
had fewer comorbidities than those with complete data. A com-
parison of observed and imputed values for BMI, the one contin-
uous variable that was imputed, are also summarised in Appendix
Figs. A4 and A5.Observed risks of knee/hip replacement and mortality
Cumulative incidence of knee and hip replacement in the 9-year
period following primary care diagnosis was 9.4% and 11.6%
respectively. Cumulative incidences stratified by participant char-
acteristics of interest are summarised in Table II. Those patients in
the oldest age quartile had a substantially lower cumulative inci-
dence of both knee and hip replacement than younger patients,
males had a substantially higher cumulative incidence of hip
replacement than females, and cumulative incidence of knee
replacement was greater for those with a higher BMI. The hazard
ratios estimated for explanatory factors in each of the cause-
specific survival models for knee replacement and death or hip
replacement and death are detailed in Appendix Tables A2 and A3.
Estimates for models based on complete case data were similar,
Appendix Tables A4 and A5.
Average lifetime risks of knee and hip replacement
At diagnosis, the average participant with knee osteoarthritis
was a non-smoking 69-year-old woman in the fourth MEDEA
quintile, with a Charlson score of 0 and a BMI of 30. At diagnosis, the
average participant with hip osteoarthritis was a non-smoking 70-
year-old woman living rurally, with a Charlson score of 0 and a BMI
of 29. For participants with these characteristics at diagnosis, the
parametric models indicated that the risks of knee and hip
replacement peaked in the second year after diagnosis, then fell
over time (Fig. 1). After accounting for the competing risk of mor-
tality, these translated into a lifetime risk of knee replacement
following a diagnosis of knee osteoarthritis of 30% (95% CI: 25e36%)
and a lifetime risk of hip replacement following a diagnosis of hip
osteoarthritis of 14% (10e19%).
Participant characteristics and lifetime risks of knee/hip replacement
Lifetime risk of knee and hip replacement following a diagnosis
of knee or hip osteoarthritis generally fell as age at diagnosis
increased (Fig. 2). Younger women generally had a slightly higher
lifetime risk of knee replacement than youngermen. For example, a
60-year-old woman had a 37% (27e50%) lifetime risk of knee
replacement, while a 60-year-old man had a 30% (22e46%) risk.
However, men had a substantially higher lifetime risk of hip
replacement than women at younger ages. An average 60-year-old
man, for example, had a 30% (25e36%) lifetime risk of hip
replacement after a diagnosis of hip osteoarthritis, while a 60-year-
old woman had a 17% (12e24%) lifetime risk.
A higher BMI was associated with a substantially higher lifetime
risk of knee replacement, but relatively little difference in lifetime
risk of hip replacement (see Fig. 3 for the partial effect of BMI on
transition probabilities, and Fig. 4 for the partial effect on lifetime
risks). Holding other explanatory variables fixed at their average,
lifetime risk of knee replacement after a diagnosis of knee osteo-
arthritis was 24% (20e28%) for a BMI of 25 which increased to 32%
(26e37%) for a BMI of 35. Meanwhile, the lifetime risk of hip
replacement after a diagnosis of hip osteoarthritis was 12% (9e17%)
for a BMI of 25% and 15% (11e19%) for a BMI of 35. Differences in
comorbidities, smoking status, and socioeconomic status and
rurality had relatively little effect on lifetime risk of knee or hip
replacement (Appendix Figures A9-A11).
Discussion
This is to our knowledge the first study to assess the lifetime
risks of knee or hip replacement for a patient diagnosed with knee
or hip osteoarthritis in a primary care setting. Despite the
Table I
Participant characteristics at the time of a knee or hip osteoarthritis diagnosis
Knee osteoarthritis cohort Hip osteoarthritis cohort
N 48,311 15,105
Age at diagnosis (median [IQR]) 69 [62, 77] 70 [62, 78]
Age at diagnosis group* (%)
1st (youngest) 11,436 (23.7) 3,503 (23.2)
2nd 11,212 (23.2) 3,666 (24.3)
3rd 13,034 (27.0) 3,944 (26.1)
4th (oldest) 12,629 (26.1) 3,992 (26.4)
Gender: male (%) 16,076 (33.3) 6,024 (39.9)
Charlson score (%)
0 25,967 (53.7) 7,634 (50.5)
1 12,258 (25.4) 3,779 (25.0)
2 5,840 (12.1) 1,982 (13.1)
3þ 4,246 (8.8) 1,710 (11.3)
BMI (median [IQR]) 30.4 [27.5, 33.9] 29.1 [26.5, 32.3]
BMI group (%)
Normal or underweight (<25) 2,401 (5.0) 1,170 (7.7)
Overweight (25 and < 30) 9,550 (19.8) 3,444 (22.8)
Obese class I (30 and < 35) 8,770 (18.2) 2,372 (15.7)
Obese class II (35 and < 40) 3,538 (7.3) 788 (5.2)
Obese class III (40) 1,437 (3.0) 2,10 (1.4)
Missing 22,615 (46.8) 7,121 (47.1)
MEDEA quintile or rural (%)
1st (least deprived) 4,708 (9.7) 1,726 (11.4)
2nd 6,971 (14.4) 2,326 (15.4)
3rd 8,676 (18.0) 2,666 (17.6)
4th 9,472 (19.6) 2,736 (18.1)
5th (most deprived) 7,298 (15.1) 2,010 (13.3)
Rural 9,244 (19.1) 2,938 (19.5)
Missing 1,942 (4.0) 703 (4.7)
Smoking status (%)
Non-smoker 32,128 (66.5) 9,328 (61.8)
Ex-smoker 6,307 (13.1) 2,334 (15.5)
Current smoker 4,140 (8.6) 1,656 (11.0)
Missing 5,736 (11.9) 1,787 (11.8)
* Age groups based on quartiles for knee osteoarthritis cohort: 50 to 62, 62 to 69, 69 to 77, 77 to 105, and quartiles for hip osteoarthritis: 50 to
62, 62 to 70, 70 to 78, 78 to 103. MEDEA is a measure of socioeconomic status developed for Catalonia (Spain), with those living in rural areas
having a distinct category. BMI: body mass index; IQR: interquartile range.
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diagnosis, we find that the lifetime risks of knee and hip replace-
ment are less than one-third and less than one-sixth following a
diagnosis of knee osteoarthritis and hip osteoarthritis, respectively.
The risk of undergoing a knee or hip replacement peaks in the
second year after diagnosis, then steadily falls.
Older participants generally had lower lifetime risks of both
knee and hip replacement than younger participants. Young
women had a lower lifetime risk of hip replacement than young
men. The lifetime risk of knee replacement increased as BMI
increased.Study findings in context
We found that joint replacement was not inevitable following a
GP diagnosis of osteoarthritis. This finding is consistent with pre-
vious research into the structural and symptomatic progression of
osteoarthritis9e11. As would be expected, our estimates for lifetime
risks of joint replacement following diagnosis of osteoarthritis were
higher than the lifetime risks previously estimated for the general
population27e29. One previous study combined prevalence and
progression estimates from the literature to estimate that a 25-year
old with no history of knee injury would have a 6% lifetime risk of
knee replacement30. This latter study estimated that 13.5% of the
cohort would develop osteoarthritis, implying a 45% lifetime risk of
knee replacement for those diagnosed. Although above the esti-
mate for average lifetime risk found in our study, it is not
dramatically so.Risk of knee and hip replacement appears to be highest in the
second year for those at average age at time of osteoarthritis
diagnosis. This implies that there is a sizeable proportion of pa-
tients whom referral to surgery is made shortly following diagnosis.
This may be explained to some degree by rapid progression of
osteoarthritis for some patients1. It is likely though to be in large
part because of a proportion of patients being diagnosed at a late-
stage in the disease process, at which point knee or hip replace-
ment was already merited.
We identified participant characteristics associated with differ-
ences in lifetime risk. These differences could be due to variation in
need, disease progression, time at risk (i.e., risk of mortality), or
access to care.
Age at diagnosis had a substantial effect on lifetime risks of knee
and hip replacement. With mortality as a competing risk, younger
age at diagnosis was associated with a longer time at risk due to
greater life expectancy. All else being equal, lifetime risks of knee
and hip replacement can be expected to be higher for younger
patients. Age also appeared to influence cause-specific risks of knee
and hip replacement, with those older at diagnosis generally having
a reduced risk. This finding is consistent with previous research
that found those over 82 to have less than half the risk of knee and
hip replacement than younger patients, even after controlling for
severity of osteoarthritis symptoms31. Indeed, individuals aged over
85 have previously been found to receive less knee and hip
replacement relative to need than younger patients32, which is may
be due to a perception of a perceived worse risk-benefit trade-off
for surgery in the elderly.
Table II
Cumulative incidence of knee or hip replacement at 9 years follow-up
Knee OA Hip OA
KR/PY 9-year cumulative incidence (% (95% CI)) HR/PY 9-year cumulative incidence (% (95% CI))
Total 2561/209508 9.4% (8.9e9.9%) 1247/60723 11.6% (10.9e12.3%)
Age at diagnosis group* (%)
1st (youngest) 452/54625 7.7% (6.9e8.8%) 359/14779 15.0% (13.3e16.9%)
2nd 730/49643 13.0% (11.5e14.7%) 329/15124 13.0% (11.5e14.7%)
3rd 1002/56855 12.3% (11.4e13.2%) 371/16491 12.8% (11.5e14.4%)
4th (oldest) 377/48386 4.4% (3.7e5.2%) 188/14328 5.9% (5.0e6.8%)
Gender
Male 790/69000 8.4% (7.6e9.2%) 609/37361 14.5% (13.3e15.7%)
Female 1771/140508 9.9% (9.2e10.6%) 638/23362 9.7% (8.8e10.7%)
Charlson
0 1416/120475 9.7% (8.9e10.5%) 718/32869 13.2% (12.1e14.3%)
1 702/52364 9.4% (8.6e10.3%) 300/14917 10.8% (9.6e12.3%)
2 284/22691 9.5% (7.8e11.6%) 149/7450 10.6% (8.8e12.8%)
3þ 159/13978 6.3% (5.2e7.5%) 80/5487 6.0% (4.8e7.5%)
BMI group (%)
Normal or underweight (<25) 62/9556 6.3% (3.0e13.5%) 67/4361 7.8% (6.1e10.0%)
Overweight (25 and < 30) 424/39791 8.5% (7.3e9.8%) 254/13534 11.1% (9.6e12.8%)
Obese class I (30 and < 35) 543/37410 10.5% (9.5e11.7%) 205/9630 12.6% (10.7e14.8%)
Obese class II (35 and < 40) 278/15260 13.9% (11.9e16.3%) 82/3074 13.7% (11.0e17.1%)
Obese class III (40) 97/6015 14.3% (10.9e18.8%) 15/886 10.1% (6.0e16.9%)
Missing 1157/101476 8.6% (7.9e9.4%) 624/29238 11.9% (10.9e13.0%)
MEDEA quintile or rural (%)
1st (least deprived) 218/20180 7.4% (6.4e8.5%) 146/6946 11.7% (9.9e13.9%)
2nd 367/30180 10.0% (8.5e11.7%) 210/9095 12.7% (11.0e14.7%)
3rd 478/37924 10.3% (8.8e12.0%) 204/10565 10.4% (9.0e12.2%)
4th 606/41932 11.7% (10.3e13.3%) 246/11088 13.2% (11.5e15.3%)
5th (most deprived) 448/31745 11.0% (9.7e12.3%) 189/8,634 14.1% (11.8e16.9%)
Rural 377/39555 6.7% (5.8e7.6%) 213/11587 9.8% (8.4e11.4%)
Missing 67/7992 4.6% (3.6e5.9%) 39/2807 6.5% (4.7e8.9%)
Smoking status
Non-smoker 1729/133845 9.7% (8.9e10.5%) 697/36458 10.4% (9.5e11.3%)
Ex-smoker 285/23815 9.4% (7.4e11.9%) 208/8,150 13.1% (11.4e15.1%)
Current smoker 179/17950 7.4% (6.3e8.8%) 167/6393 16.2% (13.4e19.5%)
Missing 368/33897 8.9% (8.0e10.0%) 175/9721 11.5% (9.9e13.3%)
Cumulative incidence of total knee or hip replacement 9 years after a diagnosis of knee or hip osteoarthritis.
* Age groups based on quartiles for knee osteoarthritis cohort: 50 to 62, 62 to 69, 69 to 77, 77 to 105, and quartiles for hip osteoarthritis cohort: 50 to 62, 62 to 70, 70 to 78, 78
to 103. MEDEA is a measure of socioeconomic status developed for Catalonia (Spain), with those living in rural areas having a distinct category. BMI: body mass index; CI:
confidence interval; HR: hip replacement; KR: knee replacement; OA: osteoarthritis; PY: person years.
E. Burn et al. / Osteoarthritis and Cartilage 27 (2019) 1627e1635 1631Being a woman has consistently been linked with an increased
risk of developing osteoarthritis10, as reflected in our study cohorts
with both being majority women. However, our findings suggest
that once diagnosed, young men have a substantially higher life-
time risk of hip replacement than young women. Previous research
has found that the effect of sex on risk of surgery is mediated byFig. 1. Annual transition probabilities of knee and hip replacement following a diagnosis
confidence intervals (CIs). OA: osteoarthritis.willingness to undergo surgery31, which may be due to differences
in perceptions of the risks and benefits of knee and hip replacement
and general preferences for surgery33. Gender bias has also been
observed, with physicians more likely to recommend knee
replacement to a male patient than an otherwise equivalent female
patient.34of knee and hip osteoarthritis for average patient profiles. Point estimates with 95%
Fig. 2. Partial effect of age and sex on lifetime risks of knee and hip replacement after diagnosis of knee and hip osteoarthritis. Point estimates with 95% CIs. OA: osteoarthritis.
E. Burn et al. / Osteoarthritis and Cartilage 27 (2019) 1627e16351632Higher BMI was associated in this study with a substantially
increased lifetime risk of knee replacement following an osteoar-
thritis diagnosis. Higher BMI has previously been associated with
an increased risk of developing knee osteoarthritis35, greater
structural and clinical progression36e38, and an increased risk of
undergoing knee replacement among the general population39.
Higher BMI has also previously been shown to be associated with
an increased risk of knee replacement over 6 years after a GP
diagnosis of osteoarthritis using data from SIDIAP40. In contrast,
higher BMI at time of diagnosis of hip osteoarthritis appeared to
have little effect on the risk of hip replacement following that
diagnosis. This discordance has previously been found in a large
population-based cohort study, and may be explained by differ-
ences in biomechanical effects.41Fig. 3. Partial effect of body mass index (BMI) on annual transition probabilities of knee and
with 95% CIs. OA: osteoarthritis.Strengths and limitations of this study
This study was based on a large, representative sample from
routinely collected data, with lifetime risks of knee and hip
replacement estimated from time of GP diagnosis of knee or hip
osteoarthritis. The routinely collected data used, however, only
covered a window of time and so historical diagnoses and pro-
cedures may have been missed, leading to a possible underesti-
mation of comorbidities and a failure to exclude some patients, for
example those who had a diagnosis of inflammatory arthritis prior
to their observation time. In addition, further research into the
generalisability of our findings would be useful. Previous research
has shown that risks of joint replacement for the generalhip replacement following a diagnosis of knee and hip osteoarthritis. Point estimates
Fig. 4. Partial effect of BMI on lifetime risks of knee and hip replacement after diagnosis of knee and hip osteoarthritis. BMI: BMI; OA: osteoarthritis.
E. Burn et al. / Osteoarthritis and Cartilage 27 (2019) 1627e1635 1633population vary across countries27,28, and this will likely also be the
case for risks for those diagnosed with osteoarthritis.
The use of parametric survival models with flexible distributions
allowed us to estimate lifetime risk, which is an understandable,
and possibly the most pertinent, description of risk. By using
parametric models instead of lifetable methods, we were able to
thoroughly analyse the effect of patient characteristics on the risk of
knee or hip replacement and mortality. However, this approach
required extrapolation well beyond the end of study follow-up,
particularly for younger patients. This extrapolation necessarily
had a high degree of uncertainty, as reflected in thewide CIs around
estimates for younger patients.
When analysing the relationship between patient characteris-
tics and lifetime risks of knee and hip replacement, wewere limited
to those factors available in routinely collected data. Awide range of
other factors are likely to influence lifetime risk, such as willingness
to undergo knee or hip replacement and disease severity31,42. In
addition, this analysis was limited to risk of first knee or hip
replacement following a diagnosis of osteoarthritis with no data
available on laterality at diagnosis or at knee or hip replacement. If
data on laterality were available for future research, analyses
incorporating this information could provide a more detailed
assessment of prognosis.Conclusion
Knee and hip replacement are not inevitable following a GP
diagnosis of knee or hip osteoarthritis. Those with knee osteoar-
thritis have a lifetime risk of less than a third for knee replacement,
and those with hip osteoarthritis have a lifetime risk of less than a
sixth for hip replacement. These findings provide a clear indication
of prognosis for doctors and patients, which should help to inform
treatment choices after diagnosis.
Risk of knee and hip replacement generally peaked in the sec-
ond year following diagnosis in this study. This is likely because of a
late diagnosis for a proportion of the study participants, with
diagnosis made at a point where knee or hip replacement was
already merited. This finding underscores the importance of timely
diagnosis, following which non-operative treatments can be
pursued.
Lifetime risks of knee and hip replacement vary depending on
patient characteristics at diagnosis. In particular, higher BMI is
associated with an increased risk of knee replacement. Effective
weight loss interventions provided at the time of a kneeosteoarthritis diagnosis would therefore likely lead to substantial
health benefits for patients and cost savings for the health system.
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